Skip to content

Cinromide

Drug profile

Also known as: vumide

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Cinromide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including SLC6A19.

  • Molecular targets: SLC6A19 (1 listed in DrugCentral).
  • Molecular formula: C11H12BrNO; molecular weight 254.13 g/mol.

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Sodium-dependent neutral amino acid transporter B(0)AT1SLC6A19inhibitorIC50 6.40

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Cinromide is on its molecule page.

Molecular formulaC11H12BrNO
Molecular weight254.13 g/mol
CAS number—
InChIKeyLDCXGZCEMNMWIL-VOTSOKGWSA-N
PubChem CID688145
CCNC(=O)\C=C\C1=CC(Br)=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Cinromide work?

Its molecular targets in DrugCentral include SLC6A19 (inhibitor).

What is the chemical formula of Cinromide?

Cinromide has the molecular formula C11H12BrNO and a molecular weight of 254.13 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications0
FormulaC11H12BrNO
DrugCentral ID3102
Interactive profile